AI assistant
ANGIODYNAMICS INC — Director's Dealing 2022
Jul 22, 2022
32939_dirs_2022-07-22_629838a6-ce5c-4019-9945-847cae0b5d8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2022-07-20
Reporting Person: Trowbridge Stephen A (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-07-20 | Common Stock | A | 7961 | — | Acquired | 88498 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-20 | Performance Right | $ | A | 15922 | Acquired | Common Stock (15922) | Direct | |
| 2022-07-20 | Non-Qualified Stock Option (right to buy) | $21.53 | A | 18650 | Acquired | 2032-07-20 | Common Stock (18650) | Direct |
Footnotes
F1: The acquisition of 7,961 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,961 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026.
F2: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.
F3: These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026.